These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24004815)

  • 21. Effect of information about the benefits and harms of mammography on women's decision making: The InforMa randomised controlled trial.
    Pérez-Lacasta MJ; Martínez-Alonso M; Garcia M; Sala M; Perestelo-Pérez L; Vidal C; Codern-Bové N; Feijoo-Cid M; Toledo-Chávarri A; Cardona À; Pons A; Carles-Lavila M; Rue M;
    PLoS One; 2019; 14(3):e0214057. PubMed ID: 30913217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What Factors Influence Decision-Making about Breast Cancer Chemoprevention among High-Risk Women?
    Crew KD
    Cancer Prev Res (Phila); 2017 Nov; 10(11):609-611. PubMed ID: 28978567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The selective estrogen receptor modulators in breast cancer prevention.
    Li F; Dou J; Wei L; Li S; Liu J
    Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk-benefit profiles of women using tamoxifen for chemoprevention.
    Nichols HB; DeRoo LA; Scharf DR; Sandler DP
    J Natl Cancer Inst; 2015 Jan; 107(1):354. PubMed ID: 25475563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904).
    Michel AM; Yi H; Amenta J; Collins N; Vaynrub A; Umakanth S; Anderson G; Arnold K; Law C; Pruthi S; Sandoval-Leon A; Shirley R; Perdekamp MG; Colonna S; Krisher S; King T; Yee LD; Ballinger TJ; Braun-Inglis C; Mangino DA; Wisinski K; DeYoung CA; Ross M; Floyd J; Kaster A; VanderWalde L; Saphner TJ; Zarwan C; Lo S; Graham C; Conlin A; Yost K; Agnese D; Jernigan C; Hershman DL; Neuhouser ML; Arun B; Crew KD; Kukafka R
    BMC Med Inform Decis Mak; 2024 Sep; 24(1):272. PubMed ID: 39334347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of a decision aid about stratified ovarian cancer risk-management on women's knowledge and intentions: a randomised online experimental survey study.
    Meisel SF; Freeman M; Waller J; Fraser L; Gessler S; Jacobs I; Kalsi J; Manchanda R; Rahman B; Side L; Wardle J; Lanceley A; Sanderson SC;
    BMC Public Health; 2017 Nov; 17(1):882. PubMed ID: 29145813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.
    Kinsinger LS; Harris R; Woolf SH; Sox HC; Lohr KN
    Ann Intern Med; 2002 Jul; 137(1):59-69. PubMed ID: 12093250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials.
    Mocellin S; Pilati P; Briarava M; Nitti D
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26582062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer anxiety's associations with responses to a chemoprevention decision aid.
    Dillard AJ; Scherer L; Ubel PA; Smith DM; Zikmund-Fisher BJ; McClure JB; Greene S; Stark A; Fagerlin A
    Soc Sci Med; 2013 Jan; 77():13-9. PubMed ID: 23200299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Personalized Breast Cancer Risk Tool on Chemoprevention and Breast Imaging: ENGAGED-2 Trial.
    Wernli KJ; Knerr S; Li T; Leppig K; Ehrlich K; Farrell D; Gao H; Bowles EJA; Graham AL; Luta G; Jayasekera J; Mandelblatt JS; Schwartz MD; O'Neill SC
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33554037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.
    Reimers LL; Sivasubramanian PS; Hershman D; Terry MB; Greenlee H; Campbell J; Kalinsky K; Maurer M; Jayasena R; Sandoval R; Alvarez M; Crew KD
    Breast J; 2015; 21(4):377-86. PubMed ID: 25879521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Decision aid and informed decision on breast cancer screening: the "DonnaInformata-Mammografia" project.].
    Roberto A; Colombo C; Candiani G; Giordano L; Mantellini P; Paci E; Satolli R; Valenza M; Mosconi P
    Recenti Prog Med; 2018 Feb; 109(2):139-142. PubMed ID: 29493642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How should we inform women at higher risk of breast cancer about tamoxifen? An approach with a decision guide.
    McKay A; Martin W; Latosinsky S
    Breast Cancer Res Treat; 2005 Nov; 94(2):153-9. PubMed ID: 16261414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis.
    Ropka ME; Keim J; Philbrick JT
    J Clin Oncol; 2010 Jun; 28(18):3090-5. PubMed ID: 20458026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Towards informed decisions on breast cancer screening: Development and pilot testing of a decision aid for Chinese women.
    Wong IO; Lam WW; Wong CN; Cowling BJ; Leung GM; Fielding R
    Patient Educ Couns; 2015 Aug; 98(8):961-9. PubMed ID: 25959986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uptake of breast cancer preventive therapy in the UK: results from a multicentre prospective survey and qualitative interviews.
    Hackett J; Thorneloe R; Side L; Wolf M; Horne R; Cuzick J; Smith SG
    Breast Cancer Res Treat; 2018 Aug; 170(3):633-640. PubMed ID: 29687178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk versus Benefit of Chemoprevention among Raloxifene and Tamoxifen Users with a Family History of Breast Cancer.
    Anderson C; Nichols HB; House M; Sandler DP
    Cancer Prev Res (Phila); 2019 Nov; 12(11):801-808. PubMed ID: 31431499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump.
    Taylor R; Taguchi K
    Ann Fam Med; 2005; 3(3):242-7. PubMed ID: 15928228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addressing barriers to uptake of breast cancer chemoprevention for patients and providers.
    Crew KD
    Am Soc Clin Oncol Educ Book; 2015; ():e50-8. PubMed ID: 25993215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial.
    Evans R; Joseph-Williams N; Edwards A; Newcombe RG; Wright P; Kinnersley P; Griffiths J; Jones M; Williams J; Grol R; Elwyn G
    J Med Internet Res; 2010 Aug; 12(3):e27. PubMed ID: 20693148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.